Software Improves the Ability to Pinpoint Specific Genetic Mutations that Drive Cancer
https://reachmd.com/news/software-improves-the-ability-to-pinpoint-specific-genetic-mutations-that-drive-cancer/2449844/
Credit: Unsplash/CC0 Public Domain A new open-source software package called cancereffectsizeR developed by the Townsend Lab greatly improves the ability of data scientists and clinical analysts to pin…
A Unique Window Into "Original Antigenic Sin" - News
https://reachmd.com/news/a-unique-window-into-original-antigenic-sin-news/2449865/
A legendary virologist coined the term Original Antigenic Sin to reflect his frustration with the body’s bias against the first flu strain it encounters (iStock). Our immune systems react most strongly to the viral strains we encountered in our childhoods. Scientists call this original antig…
Simple Laser Treatments May Help Prevent Nonmelanoma Skin Cancer
https://reachmd.com/news/simple-laser-treatments-may-help-prevent-nonmelanoma-skin-cancer/2449850/
BOSTON – New research indicates that simple laser treatments to the skin may help to prevent the development of basal cell carcinoma and squamous cell carcinoma, which are collectively known as keratinocyte carcinoma and are the most common types of cancer diagnosed in the United States. The work w…
Nanotechnology May Improve Gene Therapy for Blindness
https://reachmd.com/news/nanotechnology-may-improve-gene-therapy-for-blindness/2449878/
Oregon Health & Science University’s Casey Eye Institute clinicians provide Luxturna, an FDA-approved gene therapy to correct blindness-causing mutations to the RPE65 gene, during a Sept. 17, 2018, surgery. Today, OHSU and Oregon State University researchers are developing a new approach to g…
New Research Identifies a Potential Treatment Target for Hepatoblastoma, The Most Common Liver Cancer in Children
https://reachmd.com/news/new-research-identifies-a-potential-treatment-target-for-hepatoblastoma-the-most-common-liver-cancer-in-children/2449868/
Newswise — Philadelphia, January 16, 2023 – Although rare compared to adult liver cancers, hepatoblastoma is the most common pediatric liver malignancy, and its incidence is increasing. In this novel study appearing in The American Journal of Pathology, published by Elsevier, investigators studyin…
Quality of Treatment for Lung Cancer Varies Widely Across the U.S.
https://reachmd.com/news/quality-of-treatment-for-lung-cancer-varies-widely-across-the-us/2449848/
Visit the News Hub Quality of treatment for lung cancer varies widely across US Researchers identify measures to improve treatment quality, health outcomes Tim Parker A new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung canc…
Durable SARS-CoV-2 Antibodies Bind to Two Viral Targets at Once
https://reachmd.com/news/durable-sars-cov-2-antibodies-bind-to-two-viral-targets-at-once/2449864/
LA JOLLA, CA—A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. That’s right: marks. Instead of targeting a single binding site on the SARS-CoV-2 Spike protein, these powerful antibodies bind to two of thes…
Frontiers in Immunology Publishes Pre-Clinical Study of Palatin's PL8177 Demonstrating Therapeutic Effects in Inflammatory Conditions
https://reachmd.com/news/frontiers-in-immunology-publishes-pre-clinical-study-of-palatins-pl8177-demonstrating-therapeutic-effects-in-inflammatory-conditions/2449843/
- Collaboration with The William Harvey Research Institute and Queen Mary University of London- PL-8177 displayed pro-resolving and anti-arthritic effects in rodentsCRANBURY, N.J., Jan. 10, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company de…
Evolution of Uniquely Human DNA Was a Balancing Act, Study Concludes
https://reachmd.com/news/evolution-of-uniquely-human-dna-was-a-balancing-act-study-concludes/2449826/
Many changes to the genomes of early humans had opposing effects from each other, possibly because of a delicate balance between improved cognition and psychiatric disease riskSAN FRANCISCO, Jan. 13, 2023 /PRNewswire/ -- Humans and chimpanzees differ in only one percent of their DNA. Human acceler…
Challenges & Successes in Human CRISPR Trials
https://reachmd.com/news/challenges-successes-in-human-crispr-trials/2449821/
A recent op-ed in the New York Times asked why scientists and clinicians aren't using CRISPR to treat more human diseases. It outlined the possibilities, the success stories, and some of the reasons why this technology is not applied more often. It also raised i…